会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 52. 发明授权
    • Indolomorphinan derivative and agent for curing and preventing cerebral
disorder
    • 吲哚并吗啡喃衍生物和治疗和预防脑病的药剂
    • US6156762A
    • 2000-12-05
    • US142794
    • 1998-09-24
    • Hiroshi NagaseYoshifumi ImamuraJunichi HirokawaSusumu MatsudaYasushi Miyauchi
    • Hiroshi NagaseYoshifumi ImamuraJunichi HirokawaSusumu MatsudaYasushi Miyauchi
    • C07D489/00C07D491/18C07D491/20A61K31/485C07D489/10
    • C07D489/00
    • The present invention provides an indolomorphinan derivative or a pharmacologically acceptable acid addition salt thereof, and an agent for curing and preventing cerebral disorders composed of the derivative and salt thereof, which is represented by the following formula (I): ##STR1## [wherein R.sup.1 represents cyclopropylmethyl or the like; R.sup.2 and R.sup.3 each represent hydroxy methoxy, or the like; R.sup.4 represents hydrogen, methyl, benzyl, 3-isothiocyanatopropyl, or the like; and (R.sup.5).sub.m represents hydrogen, substituted benzo, or the like]. The compounds of the present invention have the excellent effect of preventing damage of the cerebral nerve cells. Therefore, the compounds of the present invention are useful as medicines used for curing and preventing various cerebral diseases such as cerebral stroke, traumatic cerebral diseases, cerebral edema, and cerebral neurodegenerative diseases, ameliorating aftereffects thereof, and preventing the recurrence thereof by inhibiting various ischemic, hemorrhagic or traumatic cerebral disorders, and damages of the cerebral nerve cells caused by various nerve degenerations.
    • PCT No.PCT / JP98 / 00092 Sec。 371日期:1998年9月24日 102(e)1998年9月24日PCT PCT 1998年1月13日PCT公布。 公开号WO98 / 31684 日期:1998年7月23日本发明提供吲哚并吗啡衍生物或其药理学上可接受的酸加成盐,以及由下式(I)表示的由其衍生物和盐组成的脑病的治疗和预防剂: 其中R1表示环丙基甲基等; R2和R3各自表示羟基甲氧基等; R4代表氢,甲基,苄基,3-异硫氰基丙基等; 和(R 5)m表示氢,取代的苯并或类似物]。 本发明的化合物具有防止脑神经细胞损伤的优异效果。 因此,本发明的化合物可用作治疗和预防各种脑疾病如脑中风,创伤性脑病,脑水肿和脑神经变性疾病的药物,改善其后遗症,并通过抑制各种缺血性疾病预防其复发 ,出血性或创伤性脑病,以及由各种神经变性引起的脑神经细胞损伤。
    • 55. 发明授权
    • 4A-aryldecahydroisoquinoline compound and medicinal use of the same
    • 4A-芳基十氢异喹啉化合物及其药用
    • US5776945A
    • 1998-07-07
    • US809226
    • 1997-05-08
    • Hiroshi NagaseYoshifumi ImamuraHiroshi OhnoTakashi Endo
    • Hiroshi NagaseYoshifumi ImamuraHiroshi OhnoTakashi Endo
    • C07D217/16C07D405/12C07D217/04A61K31/46
    • C07D405/12C07D217/16
    • The present invention relates to a 4a-aryldecahydroisoquinoline compound, which is represented by a compound 1, or a pharmacologically acceptable salt thereof. ##STR1## As the results of in vitro and in vivo pharmacological evaluations, it was found that the compounds of the present invention had excellent preventive effects on ischemic death of cerebral neurocytes, suppressive effects on development of cerebral infarction, and strong analgesic and antitussive effects; therefore the compounds of the present invention can be utilized in the medicinal field as a useful cerebral cytoprotective agent, which is aimed at preventing and treating cerebrovascular disorder, ischemic cerebral disorder, cerebral neurocyte disorder, and dementia, an analgesic, and an antitussive.
    • PCT No.PCT / JP96 / 02030 Sec。 371日期:1997年5月8日 102(e)日期1997年5月8日PCT PCT 1996年7月19日PCT公布。 公开号WO97 / 03968 日期:1997年2月6日本发明涉及由化合物1表示的4a-芳基十氢异喹啉化合物或其药理学上可接受的盐。 作为体外和体内药理学评价的结果,发现本发明的化合物对脑神经细胞的缺血性死亡具有优异的预防作用,对脑梗死发展的抑制作用以及强镇痛和镇咳药 效果; 因此,本发明的化合物可用作药用领域,作为有用的脑细胞保护剂,其旨在预防和治疗脑血管障碍,缺血性脑病,脑神经细胞病和痴呆,镇痛药和镇咳药。